Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 55 | 2012 | 2020 | 4.930 |
Why?
|
Papillomavirus Vaccines | 27 | 2012 | 496 | 4.450 |
Why?
|
Papillomavirus Infections | 37 | 2011 | 1613 | 3.670 |
Why?
|
Cost-Benefit Analysis | 103 | 2017 | 5493 | 2.530 |
Why?
|
Human papillomavirus 16 | 15 | 2011 | 267 | 2.430 |
Why?
|
Human papillomavirus 18 | 14 | 2011 | 125 | 2.360 |
Why?
|
Mass Screening | 43 | 2015 | 5429 | 2.330 |
Why?
|
Maternal Mortality | 5 | 2023 | 302 | 2.240 |
Why?
|
Uterine Cervical Dysplasia | 12 | 2010 | 384 | 1.640 |
Why?
|
Vaccination | 16 | 2017 | 3384 | 1.500 |
Why?
|
Papillomaviridae | 15 | 2006 | 1119 | 1.500 |
Why?
|
Quality-Adjusted Life Years | 39 | 2017 | 1722 | 1.390 |
Why?
|
Markov Chains | 21 | 2010 | 966 | 1.320 |
Why?
|
Tumor Virus Infections | 7 | 2004 | 438 | 1.080 |
Why?
|
Alphapapillomavirus | 5 | 2011 | 218 | 1.080 |
Why?
|
AIDS-Related Opportunistic Infections | 15 | 2007 | 662 | 1.030 |
Why?
|
Health Care Costs | 21 | 2012 | 3242 | 0.990 |
Why?
|
Health Policy | 13 | 2024 | 2684 | 0.980 |
Why?
|
Helicobacter Infections | 5 | 2015 | 388 | 0.980 |
Why?
|
Stomach Neoplasms | 6 | 2015 | 1459 | 0.960 |
Why?
|
Helicobacter pylori | 5 | 2015 | 377 | 0.940 |
Why?
|
Developing Countries | 11 | 2017 | 2885 | 0.930 |
Why?
|
Vaginal Smears | 11 | 2011 | 499 | 0.890 |
Why?
|
Models, Theoretical | 22 | 2013 | 3575 | 0.880 |
Why?
|
Rotavirus Vaccines | 4 | 2011 | 62 | 0.850 |
Why?
|
Rotavirus Infections | 4 | 2011 | 84 | 0.840 |
Why?
|
Immunization Programs | 8 | 2017 | 268 | 0.820 |
Why?
|
DNA, Viral | 14 | 2011 | 2202 | 0.760 |
Why?
|
Models, Economic | 10 | 2010 | 716 | 0.700 |
Why?
|
Models, Econometric | 10 | 2010 | 216 | 0.620 |
Why?
|
Decision Support Techniques | 10 | 2016 | 1998 | 0.600 |
Why?
|
Anus Neoplasms | 5 | 2008 | 329 | 0.550 |
Why?
|
Computer Simulation | 20 | 2023 | 6241 | 0.550 |
Why?
|
Cost of Illness | 8 | 2017 | 1937 | 0.530 |
Why?
|
Colposcopy | 8 | 2008 | 150 | 0.520 |
Why?
|
Early Detection of Cancer | 6 | 2012 | 3201 | 0.510 |
Why?
|
Pepsinogen A | 1 | 2015 | 13 | 0.500 |
Why?
|
HIV Infections | 32 | 2011 | 17354 | 0.480 |
Why?
|
Sexually Transmitted Diseases, Viral | 2 | 2004 | 40 | 0.460 |
Why?
|
Abortion, Induced | 2 | 2010 | 462 | 0.450 |
Why?
|
Chlamydia trachomatis | 2 | 2006 | 239 | 0.450 |
Why?
|
Life Expectancy | 19 | 2011 | 1243 | 0.440 |
Why?
|
Gastroscopy | 1 | 2015 | 211 | 0.440 |
Why?
|
Delivery of Health Care | 7 | 2023 | 5337 | 0.420 |
Why?
|
Female | 112 | 2023 | 392705 | 0.410 |
Why?
|
Hepatitis C, Chronic | 3 | 2007 | 1032 | 0.390 |
Why?
|
Chlamydia Infections | 2 | 2006 | 365 | 0.390 |
Why?
|
Herpes Genitalis | 2 | 2003 | 150 | 0.380 |
Why?
|
Adenocarcinoma | 4 | 2015 | 6345 | 0.380 |
Why?
|
Humans | 167 | 2024 | 761596 | 0.380 |
Why?
|
Adult | 78 | 2015 | 221210 | 0.370 |
Why?
|
Precancerous Conditions | 3 | 2010 | 980 | 0.360 |
Why?
|
Anti-HIV Agents | 14 | 2011 | 4527 | 0.340 |
Why?
|
Guideline Adherence | 2 | 2011 | 2220 | 0.340 |
Why?
|
Empirical Research | 1 | 2010 | 120 | 0.340 |
Why?
|
Office Visits | 2 | 2006 | 595 | 0.340 |
Why?
|
Hepatitis C | 3 | 2004 | 1584 | 0.330 |
Why?
|
CD4 Lymphocyte Count | 19 | 2010 | 2571 | 0.330 |
Why?
|
Maternal Health Services | 3 | 2012 | 462 | 0.320 |
Why?
|
Antiretroviral Therapy, Highly Active | 10 | 2010 | 1897 | 0.320 |
Why?
|
Program Evaluation | 4 | 2012 | 2495 | 0.320 |
Why?
|
Syphilis, Congenital | 1 | 2008 | 25 | 0.320 |
Why?
|
Anti-Infective Agents | 3 | 2006 | 983 | 0.320 |
Why?
|
Cholera Vaccines | 1 | 2011 | 262 | 0.310 |
Why?
|
Viral Vaccines | 2 | 2004 | 596 | 0.310 |
Why?
|
Diagnostic Tests, Routine | 3 | 2004 | 787 | 0.310 |
Why?
|
Disease Outbreaks | 2 | 2011 | 1749 | 0.300 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2008 | 219 | 0.300 |
Why?
|
Models, Statistical | 7 | 2016 | 5079 | 0.290 |
Why?
|
United States | 45 | 2015 | 72340 | 0.290 |
Why?
|
Sensitivity and Specificity | 22 | 2010 | 14665 | 0.280 |
Why?
|
Pelvic Inflammatory Disease | 2 | 2006 | 96 | 0.270 |
Why?
|
Pneumococcal Vaccines | 1 | 2010 | 397 | 0.270 |
Why?
|
Hepatitis B Vaccines | 1 | 2007 | 178 | 0.270 |
Why?
|
Antiviral Agents | 6 | 2007 | 3060 | 0.270 |
Why?
|
Uncertainty | 3 | 2023 | 754 | 0.260 |
Why?
|
Forecasting | 4 | 2023 | 2928 | 0.260 |
Why?
|
Health Services Administration | 1 | 2006 | 63 | 0.260 |
Why?
|
Pneumococcal Infections | 1 | 2010 | 501 | 0.260 |
Why?
|
Models, Biological | 11 | 2010 | 9469 | 0.250 |
Why?
|
Monte Carlo Method | 6 | 2017 | 1258 | 0.250 |
Why?
|
Ribavirin | 2 | 2007 | 395 | 0.250 |
Why?
|
Developed Countries | 1 | 2008 | 449 | 0.250 |
Why?
|
Interferon-alpha | 3 | 2007 | 921 | 0.250 |
Why?
|
Adolescent | 28 | 2012 | 88326 | 0.250 |
Why?
|
Cholera | 1 | 2011 | 747 | 0.240 |
Why?
|
Primary Prevention | 3 | 2016 | 1186 | 0.240 |
Why?
|
Epidemiologic Research Design | 1 | 2008 | 368 | 0.240 |
Why?
|
Calibration | 4 | 2009 | 818 | 0.240 |
Why?
|
Herpesvirus 2, Human | 2 | 2003 | 191 | 0.230 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2012 | 942 | 0.230 |
Why?
|
Middle Aged | 46 | 2015 | 220921 | 0.230 |
Why?
|
Health Resources | 2 | 2006 | 935 | 0.220 |
Why?
|
Mortality | 3 | 2023 | 2902 | 0.210 |
Why?
|
Genital Neoplasms, Female | 1 | 2008 | 532 | 0.210 |
Why?
|
Family Planning Services | 3 | 2012 | 268 | 0.210 |
Why?
|
Drug Costs | 8 | 2010 | 1183 | 0.210 |
Why?
|
Pneumonia, Pneumocystis | 2 | 2002 | 242 | 0.210 |
Why?
|
Anti-Retroviral Agents | 3 | 2008 | 1784 | 0.210 |
Why?
|
Smoking | 4 | 2016 | 9053 | 0.210 |
Why?
|
DNA Probes, HPV | 3 | 2008 | 21 | 0.210 |
Why?
|
Pentamidine | 1 | 2002 | 44 | 0.200 |
Why?
|
Practice Guidelines as Topic | 4 | 2011 | 7391 | 0.200 |
Why?
|
Dapsone | 1 | 2002 | 56 | 0.200 |
Why?
|
Naphthoquinones | 1 | 2002 | 58 | 0.200 |
Why?
|
Therapeutics | 1 | 2002 | 113 | 0.200 |
Why?
|
Hepatitis B | 1 | 2007 | 705 | 0.200 |
Why?
|
Oncogene Proteins, Viral | 1 | 2003 | 340 | 0.200 |
Why?
|
Antiprotozoal Agents | 1 | 2002 | 94 | 0.190 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2006 | 4024 | 0.190 |
Why?
|
HIV | 4 | 2010 | 1582 | 0.190 |
Why?
|
Disease Progression | 14 | 2010 | 13510 | 0.190 |
Why?
|
Prenatal Diagnosis | 1 | 2008 | 1265 | 0.190 |
Why?
|
Bisexuality | 2 | 2000 | 294 | 0.190 |
Why?
|
HIV Seropositivity | 2 | 2006 | 960 | 0.190 |
Why?
|
Gonorrhea | 1 | 2005 | 346 | 0.180 |
Why?
|
Time Management | 1 | 2001 | 52 | 0.180 |
Why?
|
Mass Media | 1 | 2004 | 303 | 0.180 |
Why?
|
Pregnancy Outcome | 3 | 2011 | 2922 | 0.180 |
Why?
|
Health Education | 3 | 2004 | 1052 | 0.180 |
Why?
|
Incidence | 12 | 2015 | 21355 | 0.180 |
Why?
|
Women's Health Services | 1 | 2001 | 88 | 0.180 |
Why?
|
Pregnancy | 14 | 2012 | 29890 | 0.180 |
Why?
|
Endoscopy | 1 | 2010 | 1851 | 0.170 |
Why?
|
China | 4 | 2010 | 2374 | 0.170 |
Why?
|
Dilatation and Curettage | 2 | 2010 | 52 | 0.170 |
Why?
|
Asia | 3 | 2011 | 619 | 0.170 |
Why?
|
Vacuum Curettage | 2 | 2010 | 44 | 0.170 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2011 | 2151 | 0.170 |
Why?
|
Health Status Disparities | 1 | 2011 | 1853 | 0.170 |
Why?
|
Risk Factors | 23 | 2016 | 74213 | 0.170 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1213 | 0.170 |
Why?
|
Gambia | 2 | 2010 | 104 | 0.160 |
Why?
|
Abortifacient Agents, Nonsteroidal | 2 | 2010 | 64 | 0.160 |
Why?
|
HIV Seronegativity | 1 | 2000 | 211 | 0.160 |
Why?
|
Choice Behavior | 2 | 2002 | 825 | 0.160 |
Why?
|
Policy | 1 | 2023 | 509 | 0.160 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2004 | 610 | 0.160 |
Why?
|
Brazil | 3 | 2007 | 1230 | 0.160 |
Why?
|
Child | 19 | 2012 | 80158 | 0.160 |
Why?
|
Sexually Transmitted Diseases | 2 | 2005 | 662 | 0.160 |
Why?
|
Misoprostol | 2 | 2010 | 93 | 0.160 |
Why?
|
Communicable Disease Control | 2 | 2017 | 846 | 0.160 |
Why?
|
Drug Resistance, Viral | 4 | 2007 | 862 | 0.150 |
Why?
|
Nigeria | 2 | 2012 | 770 | 0.150 |
Why?
|
Pharyngeal Neoplasms | 2 | 2008 | 113 | 0.150 |
Why?
|
RNA, Viral | 8 | 2006 | 2846 | 0.150 |
Why?
|
Cesarean Section | 2 | 2004 | 1398 | 0.150 |
Why?
|
Risk Reduction Behavior | 2 | 2016 | 1112 | 0.150 |
Why?
|
Mexico | 3 | 2010 | 764 | 0.150 |
Why?
|
Polyethylene Glycols | 1 | 2003 | 1189 | 0.140 |
Why?
|
Direct Service Costs | 4 | 2006 | 59 | 0.140 |
Why?
|
Neoplasms | 5 | 2011 | 22173 | 0.140 |
Why?
|
Patient Compliance | 2 | 2006 | 2690 | 0.140 |
Why?
|
Mass Vaccination | 2 | 2008 | 109 | 0.140 |
Why?
|
Stochastic Processes | 2 | 2008 | 355 | 0.140 |
Why?
|
Decision Trees | 3 | 2009 | 504 | 0.140 |
Why?
|
Public Health | 5 | 2015 | 2669 | 0.140 |
Why?
|
Genetic Diseases, Inborn | 1 | 2001 | 604 | 0.140 |
Why?
|
Physical Examination | 1 | 2002 | 1255 | 0.130 |
Why?
|
South Africa | 4 | 2009 | 1843 | 0.130 |
Why?
|
Cytodiagnosis | 2 | 2004 | 447 | 0.130 |
Why?
|
Male | 44 | 2015 | 360846 | 0.130 |
Why?
|
Streptococcal Infections | 1 | 2001 | 617 | 0.130 |
Why?
|
Age Factors | 9 | 2009 | 18399 | 0.130 |
Why?
|
West Nile Fever | 2 | 2006 | 75 | 0.130 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3358 | 0.130 |
Why?
|
Health Services Research | 3 | 2011 | 1812 | 0.130 |
Why?
|
Pregnancy Trimester, First | 2 | 2010 | 907 | 0.120 |
Why?
|
Overweight | 1 | 2006 | 2417 | 0.120 |
Why?
|
Weight Loss | 1 | 2006 | 2684 | 0.120 |
Why?
|
Yoga | 2 | 2016 | 281 | 0.120 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2319 | 0.120 |
Why?
|
Caribbean Region | 3 | 2008 | 191 | 0.110 |
Why?
|
Time Factors | 11 | 2013 | 39969 | 0.110 |
Why?
|
Vietnam | 3 | 2010 | 409 | 0.110 |
Why?
|
Cholesterol | 1 | 2002 | 2905 | 0.110 |
Why?
|
Pregnancy Complications | 1 | 2007 | 2947 | 0.110 |
Why?
|
Age Distribution | 4 | 2009 | 2879 | 0.110 |
Why?
|
Risk | 4 | 2009 | 9610 | 0.110 |
Why?
|
Staphylococcal Infections | 3 | 2001 | 1407 | 0.110 |
Why?
|
Mouth Neoplasms | 2 | 2008 | 596 | 0.110 |
Why?
|
Latin America | 3 | 2008 | 410 | 0.100 |
Why?
|
Cote d'Ivoire | 3 | 2007 | 64 | 0.100 |
Why?
|
Preventive Medicine | 2 | 2007 | 246 | 0.100 |
Why?
|
Family Planning Policy | 1 | 2012 | 7 | 0.100 |
Why?
|
India | 2 | 2010 | 2348 | 0.100 |
Why?
|
Afghanistan | 1 | 2012 | 78 | 0.100 |
Why?
|
Pacific Islands | 2 | 2008 | 52 | 0.100 |
Why?
|
Quality of Life | 8 | 2008 | 13367 | 0.100 |
Why?
|
Homosexuality, Male | 1 | 2000 | 1334 | 0.100 |
Why?
|
Health Expenditures | 4 | 2018 | 2366 | 0.100 |
Why?
|
Africa, Eastern | 1 | 2011 | 76 | 0.100 |
Why?
|
Young Adult | 9 | 2013 | 59260 | 0.100 |
Why?
|
Infant | 7 | 2011 | 36193 | 0.100 |
Why?
|
Zimbabwe | 1 | 2011 | 135 | 0.090 |
Why?
|
Immunity, Herd | 1 | 2011 | 46 | 0.090 |
Why?
|
Cohort Studies | 13 | 2010 | 41495 | 0.090 |
Why?
|
Aged | 21 | 2014 | 169310 | 0.090 |
Why?
|
Costs and Cost Analysis | 3 | 2008 | 1668 | 0.090 |
Why?
|
Acquired Immunodeficiency Syndrome | 4 | 2010 | 2199 | 0.090 |
Why?
|
Health Services Accessibility | 5 | 2012 | 5440 | 0.090 |
Why?
|
France | 4 | 2005 | 497 | 0.090 |
Why?
|
Air Bags | 3 | 2001 | 12 | 0.090 |
Why?
|
Financial Support | 1 | 2011 | 117 | 0.090 |
Why?
|
International Agencies | 1 | 2011 | 243 | 0.090 |
Why?
|
Recombinant Proteins | 3 | 2007 | 6534 | 0.090 |
Why?
|
Ganciclovir | 3 | 2001 | 252 | 0.090 |
Why?
|
Teratogens | 1 | 2011 | 117 | 0.090 |
Why?
|
Insurance Claim Reporting | 1 | 2011 | 166 | 0.090 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2001 | 1413 | 0.090 |
Why?
|
Population Surveillance | 3 | 2010 | 2598 | 0.090 |
Why?
|
Risk Assessment | 7 | 2016 | 23996 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2002 | 3462 | 0.080 |
Why?
|
Marketing of Health Services | 1 | 2011 | 151 | 0.080 |
Why?
|
Directly Observed Therapy | 1 | 2010 | 139 | 0.080 |
Why?
|
Peru | 1 | 2012 | 891 | 0.080 |
Why?
|
Decision Making, Organizational | 2 | 2008 | 136 | 0.080 |
Why?
|
Prevalence | 5 | 2008 | 15733 | 0.080 |
Why?
|
Rotavirus | 1 | 2010 | 109 | 0.080 |
Why?
|
Emergency Service, Hospital | 2 | 2007 | 7879 | 0.080 |
Why?
|
Benzoxazines | 1 | 2011 | 316 | 0.080 |
Why?
|
Intensive Care, Neonatal | 1 | 2010 | 199 | 0.080 |
Why?
|
Ghana | 1 | 2010 | 315 | 0.080 |
Why?
|
Africa | 1 | 2011 | 709 | 0.080 |
Why?
|
Health Services Misuse | 1 | 2011 | 244 | 0.080 |
Why?
|
Vaccines, Conjugate | 1 | 2010 | 328 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2017 | 875 | 0.080 |
Why?
|
Reagent Strips | 1 | 2008 | 39 | 0.080 |
Why?
|
Human papillomavirus 11 | 1 | 2008 | 14 | 0.080 |
Why?
|
Human papillomavirus 6 | 1 | 2008 | 16 | 0.080 |
Why?
|
Condylomata Acuminata | 1 | 2008 | 75 | 0.080 |
Why?
|
Genetic Testing | 1 | 2001 | 3537 | 0.080 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2008 | 56 | 0.080 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2010 | 1352 | 0.080 |
Why?
|
Drug Therapy, Combination | 6 | 2006 | 6312 | 0.080 |
Why?
|
Warts | 1 | 2008 | 66 | 0.070 |
Why?
|
Cytomegalovirus Infections | 3 | 2001 | 831 | 0.070 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2011 | 339 | 0.070 |
Why?
|
Health Planning Guidelines | 1 | 2008 | 151 | 0.070 |
Why?
|
Endometrial Neoplasms | 2 | 2007 | 1366 | 0.070 |
Why?
|
Vaccines, Attenuated | 1 | 2009 | 315 | 0.070 |
Why?
|
Aged, 80 and over | 7 | 2013 | 58984 | 0.070 |
Why?
|
Vaginal Neoplasms | 1 | 2008 | 104 | 0.070 |
Why?
|
Pregnancy Trimester, Third | 1 | 2010 | 583 | 0.070 |
Why?
|
Papilloma | 1 | 2008 | 140 | 0.070 |
Why?
|
Colombia | 1 | 2008 | 282 | 0.070 |
Why?
|
Virology | 2 | 2005 | 75 | 0.070 |
Why?
|
Patient Selection | 3 | 2016 | 4244 | 0.070 |
Why?
|
Microbial Sensitivity Tests | 2 | 2005 | 1936 | 0.070 |
Why?
|
Treatment Outcome | 12 | 2014 | 64685 | 0.070 |
Why?
|
Health Status | 3 | 2014 | 4077 | 0.070 |
Why?
|
Health Status Indicators | 2 | 2002 | 970 | 0.070 |
Why?
|
Penile Neoplasms | 1 | 2008 | 161 | 0.070 |
Why?
|
Public Policy | 1 | 2010 | 559 | 0.070 |
Why?
|
False Positive Reactions | 1 | 2008 | 957 | 0.070 |
Why?
|
West Nile virus | 1 | 2006 | 77 | 0.060 |
Why?
|
Decision Making | 5 | 2008 | 3929 | 0.060 |
Why?
|
Nutrition Surveys | 1 | 2013 | 1733 | 0.060 |
Why?
|
Budgets | 2 | 2005 | 230 | 0.060 |
Why?
|
Life Style | 2 | 2016 | 3917 | 0.060 |
Why?
|
Health Care Rationing | 3 | 2007 | 437 | 0.060 |
Why?
|
Africa South of the Sahara | 1 | 2008 | 744 | 0.060 |
Why?
|
Vulvar Neoplasms | 1 | 2008 | 263 | 0.060 |
Why?
|
Penicillins | 1 | 2008 | 402 | 0.060 |
Why?
|
Smoking Cessation | 2 | 2016 | 2057 | 0.060 |
Why?
|
Atrioventricular Node | 1 | 2006 | 180 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2011 | 21019 | 0.060 |
Why?
|
Sentinel Surveillance | 1 | 2007 | 291 | 0.060 |
Why?
|
Carcinoma | 2 | 2009 | 2330 | 0.060 |
Why?
|
Adolescent Health Services | 1 | 2007 | 218 | 0.060 |
Why?
|
National Health Programs | 1 | 2008 | 440 | 0.060 |
Why?
|
HIV Fusion Inhibitors | 1 | 2005 | 82 | 0.060 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2007 | 284 | 0.060 |
Why?
|
Immunotherapy, Active | 1 | 2004 | 59 | 0.060 |
Why?
|
Urban Health | 1 | 2007 | 532 | 0.060 |
Why?
|
Child, Preschool | 5 | 2011 | 42232 | 0.060 |
Why?
|
Actuarial Analysis | 1 | 2004 | 372 | 0.060 |
Why?
|
Triage | 2 | 2008 | 986 | 0.060 |
Why?
|
Heart Block | 1 | 2006 | 386 | 0.060 |
Why?
|
Hong Kong | 1 | 2004 | 166 | 0.060 |
Why?
|
Rape | 1 | 2005 | 131 | 0.060 |
Why?
|
Referral and Consultation | 2 | 2008 | 3600 | 0.060 |
Why?
|
Obesity | 1 | 2006 | 12947 | 0.060 |
Why?
|
Cancer Vaccines | 1 | 2011 | 1051 | 0.060 |
Why?
|
Evidence-Based Practice | 1 | 2008 | 495 | 0.060 |
Why?
|
Germany | 1 | 2006 | 875 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2008 | 1336 | 0.050 |
Why?
|
HIV-1 | 5 | 2007 | 6863 | 0.050 |
Why?
|
Chemoprevention | 2 | 2002 | 326 | 0.050 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2005 | 303 | 0.050 |
Why?
|
Italy | 1 | 2005 | 842 | 0.050 |
Why?
|
Preventive Health Services | 2 | 2015 | 567 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2010 | 26202 | 0.050 |
Why?
|
Acetic Acid | 1 | 2002 | 60 | 0.050 |
Why?
|
Income | 2 | 2002 | 1877 | 0.050 |
Why?
|
Anti-Obesity Agents | 1 | 2006 | 227 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2005 | 330 | 0.050 |
Why?
|
Diet, Reducing | 1 | 2006 | 485 | 0.050 |
Why?
|
Neisseria gonorrhoeae | 1 | 2005 | 239 | 0.050 |
Why?
|
Social Class | 1 | 2011 | 2004 | 0.050 |
Why?
|
Atovaquone | 1 | 2002 | 56 | 0.050 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2008 | 491 | 0.050 |
Why?
|
Body Constitution | 1 | 2002 | 273 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2003 | 6815 | 0.050 |
Why?
|
Resource Allocation | 1 | 2004 | 350 | 0.050 |
Why?
|
Massachusetts | 3 | 2011 | 8833 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4687 | 0.050 |
Why?
|
Genotype | 3 | 2007 | 12990 | 0.050 |
Why?
|
Pregnancy, Ectopic | 1 | 2003 | 142 | 0.050 |
Why?
|
Infant Equipment | 1 | 2001 | 23 | 0.050 |
Why?
|
Medical Assistance | 1 | 2002 | 108 | 0.050 |
Why?
|
Cause of Death | 3 | 2010 | 3683 | 0.050 |
Why?
|
Social Values | 1 | 2002 | 225 | 0.050 |
Why?
|
Fibrosis | 1 | 2008 | 2049 | 0.050 |
Why?
|
Cost Allocation | 1 | 2001 | 49 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2002 | 397 | 0.050 |
Why?
|
Rural Health Services | 1 | 2005 | 384 | 0.050 |
Why?
|
Television | 1 | 2004 | 408 | 0.050 |
Why?
|
Condoms | 1 | 2003 | 331 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2007 | 14608 | 0.050 |
Why?
|
Value of Life | 1 | 2001 | 98 | 0.050 |
Why?
|
Automobiles | 1 | 2001 | 111 | 0.050 |
Why?
|
Heterosexuality | 1 | 2003 | 309 | 0.050 |
Why?
|
Pelvic Pain | 1 | 2003 | 298 | 0.040 |
Why?
|
Vancomycin | 2 | 2001 | 503 | 0.040 |
Why?
|
Netherlands | 1 | 2005 | 2221 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 2005 | 1479 | 0.040 |
Why?
|
State Health Plans | 1 | 2002 | 219 | 0.040 |
Why?
|
Delivery, Obstetric | 1 | 2007 | 941 | 0.040 |
Why?
|
Women, Working | 1 | 2001 | 86 | 0.040 |
Why?
|
Pacemaker, Artificial | 1 | 2006 | 807 | 0.040 |
Why?
|
Cardiovascular Diseases | 3 | 2016 | 15502 | 0.040 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2002 | 348 | 0.040 |
Why?
|
Cardiovascular Agents | 1 | 2006 | 840 | 0.040 |
Why?
|
Survivors | 1 | 2010 | 2371 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2002 | 675 | 0.040 |
Why?
|
Policy Making | 1 | 2002 | 542 | 0.040 |
Why?
|
Survival Analysis | 3 | 2007 | 10090 | 0.040 |
Why?
|
Healthy People Programs | 1 | 2018 | 54 | 0.040 |
Why?
|
Salaries and Fringe Benefits | 1 | 2001 | 257 | 0.040 |
Why?
|
Viral Load | 2 | 2010 | 3332 | 0.040 |
Why?
|
Homosexuality | 1 | 1999 | 267 | 0.040 |
Why?
|
Debridement | 1 | 2001 | 493 | 0.040 |
Why?
|
Educational Status | 2 | 2003 | 2522 | 0.040 |
Why?
|
International Cooperation | 2 | 2015 | 1422 | 0.040 |
Why?
|
AIDS Vaccines | 1 | 2004 | 896 | 0.040 |
Why?
|
Logistic Models | 2 | 2011 | 13255 | 0.040 |
Why?
|
Mammography | 1 | 2008 | 2430 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2014 | 10212 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2002 | 4853 | 0.040 |
Why?
|
Public Health Practice | 1 | 2000 | 219 | 0.040 |
Why?
|
Infertility, Female | 1 | 2003 | 760 | 0.040 |
Why?
|
Posture | 1 | 2001 | 957 | 0.030 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 1 | 1996 | 27 | 0.030 |
Why?
|
Medical Oncology | 1 | 2009 | 2321 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2001 | 443 | 0.030 |
Why?
|
Safety | 1 | 2001 | 1149 | 0.030 |
Why?
|
Cytomegalovirus | 2 | 2001 | 756 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2001 | 637 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2006 | 1490 | 0.030 |
Why?
|
Biopsy | 1 | 2008 | 6766 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2001 | 836 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2007 | 11120 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 2297 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2003 | 1265 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2001 | 816 | 0.030 |
Why?
|
Air Pollution, Indoor | 1 | 2003 | 901 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3810 | 0.030 |
Why?
|
Sex Factors | 1 | 2009 | 10554 | 0.030 |
Why?
|
Child Behavior | 1 | 2001 | 847 | 0.030 |
Why?
|
Urban Population | 1 | 2003 | 2036 | 0.030 |
Why?
|
Morbidity | 1 | 2001 | 1752 | 0.030 |
Why?
|
Frail Elderly | 1 | 2001 | 765 | 0.030 |
Why?
|
Information Dissemination | 1 | 2004 | 1126 | 0.030 |
Why?
|
Blotting, Western | 1 | 2003 | 5035 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2002 | 2426 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2001 | 6075 | 0.030 |
Why?
|
Attitude to Health | 1 | 2004 | 2025 | 0.030 |
Why?
|
Community Health Planning | 1 | 2015 | 164 | 0.030 |
Why?
|
Liver Diseases | 1 | 2003 | 1297 | 0.030 |
Why?
|
Software | 1 | 2008 | 4434 | 0.030 |
Why?
|
Rural Population | 1 | 2005 | 2287 | 0.030 |
Why?
|
Peritonitis | 1 | 1996 | 368 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2008 | 20100 | 0.030 |
Why?
|
Information Systems | 1 | 1976 | 396 | 0.030 |
Why?
|
Financing, Organized | 1 | 2015 | 204 | 0.030 |
Why?
|
Investments | 1 | 2015 | 147 | 0.030 |
Why?
|
Medicaid | 2 | 2005 | 2818 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2003 | 2827 | 0.030 |
Why?
|
Gynecology | 1 | 1999 | 526 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3415 | 0.030 |
Why?
|
Body Composition | 1 | 2002 | 2426 | 0.030 |
Why?
|
Genomics | 1 | 2009 | 5821 | 0.030 |
Why?
|
Databases, Factual | 1 | 2008 | 7968 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2003 | 1935 | 0.030 |
Why?
|
Obstetrics | 1 | 1999 | 666 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2005 | 5112 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2001 | 2188 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2001 | 1529 | 0.020 |
Why?
|
Financing, Government | 1 | 2015 | 472 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6938 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 709 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2002 | 3313 | 0.020 |
Why?
|
Goals | 1 | 2015 | 711 | 0.020 |
Why?
|
Alkynes | 1 | 2011 | 320 | 0.020 |
Why?
|
Prognosis | 2 | 2016 | 29629 | 0.020 |
Why?
|
Seat Belts | 2 | 2001 | 60 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2004 | 4016 | 0.020 |
Why?
|
Population | 1 | 2009 | 141 | 0.020 |
Why?
|
Cyclopropanes | 1 | 2011 | 432 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2016 | 740 | 0.020 |
Why?
|
Spain | 1 | 2010 | 487 | 0.020 |
Why?
|
Vaccines | 1 | 2017 | 844 | 0.020 |
Why?
|
Cytological Techniques | 1 | 2010 | 218 | 0.020 |
Why?
|
Survival Rate | 1 | 2002 | 12723 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2007 | 39106 | 0.020 |
Why?
|
Recurrence | 1 | 2001 | 8466 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2001 | 15266 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2002 | 3206 | 0.020 |
Why?
|
Cross Infection | 1 | 1996 | 1422 | 0.020 |
Why?
|
American Cancer Society | 1 | 2007 | 69 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2002 | 4317 | 0.020 |
Why?
|
Toxoplasmosis, Cerebral | 1 | 2006 | 19 | 0.020 |
Why?
|
Drug Resistance, Microbial | 2 | 2001 | 825 | 0.020 |
Why?
|
Mycobacterium Infections | 1 | 2006 | 122 | 0.020 |
Why?
|
Isoproterenol | 1 | 2006 | 395 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 1998 | 2492 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2001 | 7406 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2003 | 15843 | 0.020 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 432 | 0.010 |
Why?
|
Georgia | 1 | 2005 | 185 | 0.010 |
Why?
|
Probability | 1 | 2010 | 2477 | 0.010 |
Why?
|
Regression Analysis | 2 | 2006 | 6345 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2006 | 345 | 0.010 |
Why?
|
Social Justice | 1 | 2009 | 478 | 0.010 |
Why?
|
Asthma | 1 | 2003 | 6234 | 0.010 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 621 | 0.010 |
Why?
|
Psychiatry | 1 | 1976 | 1693 | 0.010 |
Why?
|
Blood Donors | 1 | 2006 | 345 | 0.010 |
Why?
|
Tachycardia | 1 | 2006 | 600 | 0.010 |
Why?
|
Hospitalization | 2 | 2001 | 10721 | 0.010 |
Why?
|
Health Promotion | 1 | 2015 | 2214 | 0.010 |
Why?
|
Mycoses | 1 | 2006 | 386 | 0.010 |
Why?
|
Haiti | 1 | 2005 | 550 | 0.010 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2006 | 506 | 0.010 |
Why?
|
Occupations | 1 | 2005 | 515 | 0.010 |
Why?
|
World Health Organization | 1 | 2008 | 1322 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2007 | 1784 | 0.010 |
Why?
|
Algorithms | 2 | 2002 | 14033 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2006 | 12059 | 0.010 |
Why?
|
Retrospective Studies | 4 | 2006 | 80647 | 0.010 |
Why?
|
Pediatric Assistants | 1 | 2001 | 8 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2006 | 866 | 0.010 |
Why?
|
Gestational Age | 1 | 2010 | 3577 | 0.010 |
Why?
|
Continuity of Patient Care | 1 | 2009 | 1069 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2006 | 774 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2009 | 1836 | 0.010 |
Why?
|
Natural Childbirth | 1 | 2000 | 15 | 0.010 |
Why?
|
Cefazolin | 1 | 2001 | 94 | 0.010 |
Why?
|
Sex Distribution | 1 | 2006 | 2280 | 0.010 |
Why?
|
Infant, Premature | 1 | 2010 | 2107 | 0.010 |
Why?
|
Vancomycin Resistance | 1 | 2001 | 125 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1702 | 0.010 |
Why?
|
Methicillin Resistance | 1 | 2001 | 198 | 0.010 |
Why?
|
Uterine Cervical Diseases | 1 | 2000 | 73 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2016 | 4481 | 0.010 |
Why?
|
Cephalosporins | 1 | 2001 | 198 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2006 | 858 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6228 | 0.010 |
Why?
|
Patient Simulation | 1 | 2002 | 298 | 0.010 |
Why?
|
Florida | 1 | 2001 | 431 | 0.010 |
Why?
|
Sexual Partners | 1 | 2005 | 796 | 0.010 |
Why?
|
Seasons | 1 | 2006 | 1520 | 0.010 |
Why?
|
Drug Resistance | 1 | 2006 | 1596 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2005 | 1186 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2001 | 17904 | 0.010 |
Why?
|
Exercise | 1 | 2016 | 5890 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2006 | 1301 | 0.010 |
Why?
|
New York | 1 | 2001 | 874 | 0.010 |
Why?
|
Organizational Innovation | 1 | 2002 | 537 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 1997 | 3206 | 0.010 |
Why?
|
Organizational Policy | 1 | 2001 | 432 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1626 | 0.010 |
Why?
|
Premature Birth | 1 | 2010 | 1782 | 0.010 |
Why?
|
State Government | 1 | 2001 | 384 | 0.010 |
Why?
|
Eligibility Determination | 1 | 2002 | 421 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2006 | 1391 | 0.010 |
Why?
|
Diet | 1 | 2016 | 8075 | 0.010 |
Why?
|
Length of Stay | 2 | 2005 | 6426 | 0.010 |
Why?
|
Self Efficacy | 1 | 2002 | 638 | 0.010 |
Why?
|
Efficiency, Organizational | 1 | 2002 | 695 | 0.010 |
Why?
|
Saskatchewan | 1 | 1976 | 8 | 0.010 |
Why?
|
Malaria | 1 | 2006 | 1227 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2002 | 1386 | 0.010 |
Why?
|
Connecticut | 1 | 1996 | 364 | 0.010 |
Why?
|
Immunization | 1 | 2000 | 1227 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2850 | 0.010 |
Why?
|
Enterococcus | 1 | 1996 | 159 | 0.010 |
Why?
|
Treatment Failure | 1 | 2001 | 2643 | 0.010 |
Why?
|
Physician's Role | 1 | 2001 | 917 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1997 | 755 | 0.010 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 1996 | 238 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2002 | 2696 | 0.010 |
Why?
|
Heart Rate | 1 | 2006 | 4195 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 1996 | 343 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2006 | 8527 | 0.010 |
Why?
|
Craniocerebral Trauma | 1 | 1998 | 490 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2009 | 4331 | 0.010 |
Why?
|
Peripheral Vascular Diseases | 1 | 1996 | 488 | 0.010 |
Why?
|
Serum Albumin | 1 | 1996 | 672 | 0.010 |
Why?
|
Tuberculosis | 1 | 2006 | 2017 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2001 | 1457 | 0.010 |
Why?
|
Community Mental Health Services | 1 | 1976 | 392 | 0.010 |
Why?
|
Bronchi | 1 | 1997 | 845 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2005 | 26129 | 0.010 |
Why?
|
Europe | 1 | 1999 | 3420 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 9280 | 0.010 |
Why?
|
Pilot Projects | 1 | 2005 | 8633 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2003 | 2330 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9319 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2005 | 7828 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2002 | 1940 | 0.010 |
Why?
|
Equipment Design | 1 | 1998 | 3511 | 0.010 |
Why?
|
Research Design | 1 | 2006 | 6180 | 0.010 |
Why?
|
Patient Admission | 1 | 1996 | 1367 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1996 | 1200 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 2002 | 12463 | 0.000 |
Why?
|
Comorbidity | 1 | 1996 | 10508 | 0.000 |
Why?
|
Prospective Studies | 1 | 2006 | 54423 | 0.000 |
Why?
|
Alzheimer Disease | 1 | 2000 | 8601 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 1996 | 5841 | 0.000 |
Why?
|